N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide
C31H36F2N2O3S — CID 91401261
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide
N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide (PubChem CID 91401261) has the molecular formula C31H36F2N2O3S and a molecular weight of 554.70 g/mol. Its IUPAC name is N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide.
Molecular Properties
| Compound Name | N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide |
|---|---|
| PubChem CID | 91401261 |
| Molecular Formula | C31H36F2N2O3S |
| Molecular Weight | 554.70 g/mol |
| Exact Mass | 554.24 |
| IUPAC Name | N-[1-[3,3-bis(4-fluorophenyl)propyl]piperidin-4-yl]-2-(4-methylsulfonylphenyl)butanamide |
| SMILES | CCC(C(=O)NC1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(S(C)(=O)=O)cc1 |
| InChI | InChI=1S/C31H36F2N2O3S/c1-3-29(22-8-14-28(15-9-22)39(2,37)38)31(36)34-27-16-19-35(20-17-27)21-18-30(23-4-10-25(32)11-5-23)24-6-12-26(33)13-7-24/h4-15,27,29-30H,3,16-21H2,1-2H3,(H,34,36) |
| InChIKey | UTZMKKIFRMUGGI-UHFFFAOYSA-N |
| XLogP | 5.66 |
| TPSA | 66.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 554.70 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91401261 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.